Editing CSIRO (section)

===CSIRO–Novartis–DataTrace scandal===
On 11 April 2013, the ''[[Sydney Morning Herald]]'' ran a story on how CSIRO had "duped" the Swiss-based pharmaceutical giant [[Novartis]] into purchasing an anti-counterfeit technology for its vials of injectable [[Voltaren]]. The invention was marketed by a small Australian company called DataTrace DNA as a method of identifying fake vials, on the basis that a unique tracer code developed by CSIRO was embedded in the product. However, the code sold to Novartis for more than A$2M was apparently not unique, and was based on a "cheap tracer ... bought in bulk from a Chinese distributor". Novartis was contractually bound not to reverse-engineer the tracer to verify its uniqueness. The ''Sydney Morning Herald'' report alleges that this was done with the knowledge of key CSIRO personnel.<ref>{{cite news |title=How the CSIRO cheated a global drugs giant |url=http://www.smh.com.au/technology/sci-tech/how-the-csiro-cheated-a-global-drugs-giant-20130410-2hluf.html |access-date=12 April 2012 |newspaper= The Sydney Morning Herald |date=11 April 2012}}</ref>

CSIRO has since conducted a full review of the allegations and found no evidence to support them.<ref>{{cite web |url=http://www.csiro.au/en/Portals/Media/CSIRO-review-of-issues-raised-about-CSIROs-interactions-with-DataTrace.aspx |title=CSIRO review of issues raised about CSIRO's interactions with DataTrace |publisher=Commonwealth Scientific and Industrial Research Organisation |date=11 August 2013 |access-date=7 September 2013}}</ref>